Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects ≥1 Month to <4 Years With Partial-onset Seizures

NCT02477839 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

255

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy With Partial-onset Seizures

Interventions

DRUG: Lacosamide
OTHER: Placebo

Sponsor

UCB BIOSCIENCES, Inc.